Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1007420170150010027
Mood and Emotion
2017 Volume.15 No. 1 p.27 ~ p.33
Korean Medication Algorithm for Depressive Disorder 2017 (IV) : The Subtypes of Depression
Park Young-Min

Kim Won
Wang Hee-Ryung
Woo Young-Sup
Seo Jeong-Seok
Jeong Jong-Hyun
Shim Se-Hoon
Lee Jung-Goo
Jon Duk-In
Min Kyung-Jun
Bahk Won-Myong
Abstract
Objectives : Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) was produced based on revision of the third version, Korean Medication Algorithm Project for Depressive Disorder 2012 (KMAPDD 2012). KMAP-DD 2017 reflects the latest trends and new research in the treatment of depression.

Methods : A total of 144 psychiatrists with excellent clinical experience and academic achievements in treating depression were selected. The survey of KMAP-DD 2017 was sent to them through e-mail. Of these, 79 psychiatrists answered the survey. The survey consisted of 44 questionnaires including seven parts. Each treatment strategy was categorized into three classifications of recommendation as first-line, second-line, and third-line, based on the 95% confidence interval.

Results : The results of KMAP-DD 2017 were almost similar to those of KMAP-DD 2012. However, the preference for serotonin-norepinephrine reuptake inhibitor such as venlafaxine was increased, as compared with KMAP-DD 2012. In case of anxious distress and mixed features, the preference for atypical antipsychotics as well as selective serotonin reuptake inhibitor was high.

Conclusion : KMAP-DD 2017 provides a useful guide for treating the subtypes of major depression, based on expert consensus
KEYWORD
Korean medication algorithm for depressive disorder 2017, Major depression, Pharmacotherapy, Subtype
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø